Logo image
Nitric oxide mediates caeruleininduced suppression of locomotor activity
Journal article   Peer reviewed

Nitric oxide mediates caeruleininduced suppression of locomotor activity

V. Volke, A. Soosaar, S. Kõks, M. Bourin, P.T. Männistö and E. Vasar
Neuropeptides, Vol.30(4), pp.323-326
1996
url
Link to Published Version *Subscription may be requiredView

Abstract

Caerulein, a non-selective agonist of cholecystokinin (CCK) receptors, is shown to suppress locomotor activity in rodents via stimulation of CCKA receptors. In the present study we examined the possible involvement of nitric oxide (NO) in caerulein-induced hypolocomotion in rats. Caerulein (10 μg/kg) markedly decreased the horizontal and vertical components of locomotor activity in rats measured in dark motility boxes. Pretreatment with a nitric oxide synthase inhibitor NG-nitro-l-arginine methyl ester (l-NAME), at 5 mg/kg i.p., abolished the inhibiting action of caerulein on the horizontal activity, but did not affect the reduced frequency of rearing. The other doses of l-NAME (1, 10 and 20 mg/kg) were ineffective against caerulein. As L-NAME at this dose range does not stimulate locomotor activity, it is likely that NO is involved in the motor suppressant effect of systemically administered caerulein.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.195 Neuroendocrine & Intestinal Disorders
1.195.1096 Gastrin/CCK Functions
Web Of Science research areas
Endocrinology & Metabolism
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image